Over the next decade, the meningitis B vaccine could prevent up to 4,000 cases of meningococcal disease in children younger than five years in the UK.
Britain became the first country to implement a vaccination program against meningitis B for all newborn babies, which is fatal in one in 10 cases. Campaigners hope the vaccine, which will be given to babies at two, four and 12 months old, will prevent up to 4,000 cases by 2025.
It is billed as the world's first nationwide publicly-funded program against the infection.
Trials found that the vaccine was effective against 88 percent of the hundreds of strains of meningococcal group B bacteria.
"Over the next decade this vaccine could potentially prevent up to 4,000 cases of meningococcal disease in children younger than five years in the UK," said Christopher Head, from the Meningitis Research Foundation.
Sue Davie, chief executive of the charity Meningitis Now, called the move a "massive step forward."
Group B is the most common meningitis in Britain, with around 1,700 cases diagnosed each year. Babies already receive a meningitis C vaccination.
Advertisement
"Since the vaccine was licensed, almost a million doses have been given, with no safety concerns identified," it said.
Advertisement
Source-AFP